Table 1

Baseline characteristics of the study population

Women
(n=561)
Men
(n=615)
General (mean (SD) or median (IQR))
 Age (years)71 (12)67 (12)
 Ethnicity, n (%)
  Native Dutch471 (84.0)478 (77.7)
  First-generation immigrant54 (9.6)88 (14.3)
  Second-generation immigrant36 (6.4)49 (8.0)
 Income (€)17,435(10,733–26,391)32,351(18,545–46,647)
 Current smoker, n (%)158 (28.2)167 (27.2)
 Ejection fraction, n (%)162 (28.9)291 (47.3)
  <40%86 (15.3)123 (20.0)
  40%–49%272 (48.5)155 (25.2)
  ≥50% not recorded41 (7.3)46 (7.5)
Medical history and comorbidities, n (%)
 Hypertension309 (55.1)274 (44.6)
 Diabetes mellitus74 (13.2)122 (19.8)
 Coronary heart disease42 (7.5)118 (19.2)
 Cerebrovascular disease47 (8.4)52 (8.5)
 Cardiovascular intervention47 (8.4)140 (22.8)
 Arrhythmia116 (20.7)154 (25.0)
 Valvular heart disease50 (8.9)62 (10.1)
Clinical measures (mean (SD) or median (IQR))
 Body Mass Index (kg/m2)27.5 (5.6)28.1 (4.7)
 Systolic blood pressure (mm Hg)150 (26)146 (24)
 Diastolic blood pressure (mm Hg)88 (14)88 (15)
 Total cholesterol (mmol/L)5.02 (1.13)4.55 (1.13)
 Triglycerides (mmol/L)1.40 (1.00–2.10)1.60 [(.10–2.20)
 Estimated glomerular filtration rate (mL/min/1.73 m2)65 (27)66 (28)
Medication prescribed at baseline, n (%)
 ACEI/ARB428 (76.3)506 (82.3)
 Beta blocker381 (67.9)414 (67.3)
 Mineralocorticoid receptor antagonist74 (13.2)104 (16.9)
 Diuretic325 (57.9)314 (51.1)
 Number of medication classes prescribed
  1261 (46.5)251 (41.1)
  2251 (44.7)286 (46.5)
  349 (8.7)76 (12.4)
  • ACEI, ACE inhibitor; ARB, angiotensin-receptor blocker.